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Abstract 
Background: Acute appendicitis is a common cause for a visit to the emergency department and appendectomy 
represents the most common emergency procedure in surgery. The rate of negative appendectomy however has 
remained high despite modern diagnostic apparatus. Therefore, there is need for a better preoperative screening 
of patients with suspected appendicitis. Calprotectin represents a predominant protein in the cytosol of neutrophil 
granulocytes and has been extensively investigated with regard to bowel pathologies. This study investigates the 
expression of calprotectin in the lumen of the vermiform appendix of patients undergoing appendectomy for sus-
pected appendicitis.
Methods: Appendix specimens from patients undergoing emergency appendectomy for suspected acute appendi-
citis were examined. Acute appendicitis was confirmed on histopathology. The qualitative expression of calprotectin 
in the vermiform appendix specimens was analyzed using specific calprotectin antibodies.
Results: Vermiform appendix specimens from 52 patients (22 female and 30 male) including 11 with uncomplicated 
and 41 with complicated appendicitis were analyzed. Strong immunostainings were achieved with calprotectin 
antibody in the lumen of all specimens irrespective of the extent of appendicitis. Immunostaining was negative in the 
uninflamed appendix.
Conclusions: High calprotectin activity could be demonstrated within the lumen of vermiform appendix specimens 
following appendectomy for acute appendicitis. The high luminal accumulation of calprotectin-carrying cells could 
be interpreted as an invitation to study the expression of calprotectin in stool as a new diagnostic aid in patients with 
suspected appendicitis.
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Background
Abdominal pain is a frequent cause for a visit to the emer-
gency department. Pain to the lower right quadrant may 
be a sign of acute appendicitis (AA) [1]. However, similar 
symptoms may be associated with a variety of patholo-
gies [2, 3]. The clinical differentiation of AA from other 
pathologies of the right lower abdomen can be challeng-
ing. Although the clinical presentation and diagnosis of 
acute appendicitis appear fairly straight forward, the rate 
of false appendectomy, especially in female patients, is as 
high as 45 % [4–6]. Due to fear of the consequences of a 
missed diagnosis, the indication for surgery for suspected 
appendicitis is liberally made [7]. Thus appendectomy 
represents the most commonly performed emergency 
procedures in general surgery [8]. The rate of false appen-
dectomy, especially in female patients, is alarming. [5, 6]. 
Besides, complications secondary to negative appendec-
tomy might be devastating [9, 10]. The rate of negative 
appendectomy still remains high despite the use of mod-
ern imaging modalities and clinical scoring systems [5, 6, 
11]. Thus there is need for a better preoperative screen-
ing in patients with suspected appendicitis.
Calprotectin is a predominant protein found in the 
cytosol of neutrophil granulocytes and represents a docu-
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4, 12, 13]. Calprotectin has been used in the diagnostic eval-
uation of a number of bowel conditions. Extensive experi-
ence with calprotectin has been recorded in the diagnosis 
and follow-up of inflammatory bowel disease (Crohn’s dis-
ease and ulcerative colitis) [1, 13, 14]. We postulated that 
calprotectin could be an inflammatory biomarker for AA. 
This pilot study was designed to investigate the qualitative 
distribution, occurrence, and expression of calprotectin 
in the vermiform appendix of patients undergoing laparo-
scopic appendectomy for suspected acute appendicitis.
Methods
The study was conducted in accordance with the ethical 
principles of the Declaration of Helsinki and the princi-
ples of Good Clinical Practice [15]. Ethical approval was 
received from the Ethics Committee of the Witten-Herd-
ecke University. A written consent was obtained from all 
patients prior to surgery.
This is a prospective single-centre, single-blinded 
study. Patients undergoing appendectomy for suspected 
AA at HELIOS Universitätsklinikum Wuppertal, Depart-
ment of Surgery II of the Witten-Herdecke University 
were randomly drawn from the prospectively maintained 
database. The corresponding histopathology slides were 
retrieved from the Institute of Pathology and Molecu-
lar Pathology at Helios Universitätsklinikum Wuppertal, 
Witten-Herdecke University, Germany. Two independent 
pathologists analyzed the blinded slides.
A standard three-port laparoscopic appendectomy was 
performed in all cases. Surgery began with an infraumbili-
cal incision for the placement of the camera port. After cap-
nopneumoperitoneum was instilled, two more ports were 
inserted; 5 mm in the right lower abdomen and 12 mm in 
the left lower abdomen. Appendectomy was performed 
using an endoscopic lineal stapler in all cases. The resected 
vermiform appendix was removed using an endobag. Drains 
were placed as needed. Antibiotics were given as needed.
Histological evaluation
Inflammatory changes of the specimens were appraised 
on hematoxylin and eosin (HE) stained sections. The 
extent of inflammation was characterized either as 
uncomplicated (superficial, phlegmonous AA) or as 
complicated (ulcerative, gangrenous or suppurative 
AA). Complicated AA was present in cases with mucosa 
defects, while the mucosa of specimens with uncompli-
cated AA was intact. Besides, the presence of periappen-
dicitis was registered and where possible, the underlying 
etiology was documented.
Immunohistochemistry
The expression of calprotectin in the appendix specimens 
was assessed by immunohistochemistry using the DAKO 
Autostainer plus (DakoCytomation) following the manu-
facturer’s instructions. 3–5 µm sections of formalin-fixed, 
paraffin-embedded tissue were dried overnight at 37  °C 
and deparaffinized. Antigen retrieval was performed 
using the Target Retrieval Solution (Citrate pH 6.1, 10×, 
DakoCytomation, cat.no. S1699) after which the slides 
were steamed for 30 min. Endogenous peroxidases were 
blocked by incubation with Peroxidase-Blocking Solution 
(DAKO REAL ™Peroxidase-Blocking Solution, cat.no. 
S2023) for 5 min.
Immunostaining for calprotectin was achieved using 
calprotectin monoclonal mouse antibodies (Thermo Sci-
entific, Clone MAC 387, cat.no. MA5-12213). The speci-
mens were incubated for 30 min with calprotectin-specific 
primary antibody (dilution 1:500) followed by subsequent 
incubations with a visualization reagent based on a dex-
tran technology (EnVision  +  Dual Link System-HRP, 
DAKO, cat.no. K4061). The EnVision reagent consists of 
both secondary rabbit anti-mouse antibody molecules 
and horseradish peroxidase molecules linked to a com-
mon dextran polymer backbone, thus eliminating the 
need for sequential application of link antibody and per-
oxidase conjugate. Staining was completed by incubation 
with a substrate-chromogen (Liquid DAB  +  Substrate 
Chromogen System, Dako Cytomation, cat.no. K3468) for 
2 × 5 min. Enzymatic conversion of the sub-sequentially 
added chromogen resulted in the formation of a visible 
brown reaction product at the antigen site. In addition, 
the nuclei were counterstained with Mayer’s Hematoxylin 
for 2 min and sealed with coverslips.
Evaluation of immunohistochemical staining
Two experienced independent pathologists, who were 
blinded to the clinicopathological data, examined the 
expression of calprotectin in the stained sections. Immu-
nohistochemical activity was determined in epithelial 
and inflammatory cells in consideration of the amount 
of inflammatory cells within the lumen of the vermiform 
appendix. Staining intensity was graded as negative, weak 
or strong. The scores of the two pathologists were com-
pared and discrepancies resolved by re-examination to 
achieve a consensus score.
Results
Appendix specimens from 52 (22 female and 30 male) 
randomly drawn patients were analyzed. The mean age 
of the patients included was 33.6  ±  20.8  years (range 
15–77  years). Uncomplicated appendicitis without 
mucosal defects was diagnosed in 11 cases (21.2  %) 
including two cases with superficial and nine cases with 
phlegmonous AA while advanced appendicitis was seen 
in 41 cases (78.8 %) including 24 ulcerative, seven suppu-
rative and 10 gangrenous AA, Fig. 1a, b.
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Mild and severe periappendicitis was recorded in 12 
cases (23.1  %) respectively while moderate periappen-
dicitis was seen in 16 cases (30.8 %). AA was associated 
with abscess formation in five cases (9.6 %). The remain-
ing seven cases (13.5  %) showed no sign of periappen-
dicitis. The underlying etiology of AA was evident in 23 
(44.2 %) cases including 20 cases with fecolith, two cases 
with benign neoplasm of the vermiform appendix and 
one case of AA secondary to mucocele. The cause of AA 
could not be found in 29 cases (55.8 %).
The intensity of immunostaining of the vermiform 
appendix with calprotectin antibody was weak in 24 
cases (46.2 %), moderate in two cases (3.8 %) and nega-
tive in 26 cases (50.0  %), Fig.  2a, b. Excellent immu-
nostaining with calprotectin antibody was achieved 
in all cases within the appendix lumen, Fig. 3a, b. This 
finding was independent of the extent of AA. Weak 
immunohistochemical reaction was observed at the 
epithelial membrane in all cases. Immunostaining for 
calprotectin was negative in an uninflamed vermiform 
appendix specimen (Fig. 4). This control specimen was 
taken from a patient after right hemicolectomy for 
colon cancer.
Discussion
Acute appendicitis is a common illness. However, the 
clinical differentiation between AA and other potentially 
less serious conditions might be challenging. Due to fear 
of the consequences of missed diagnosis, the indication 
for emergency appendectomy is grossly made. Despite 
the use of modern diagnostic apparatus, scoring systems, 
etc. the rates of negative appendectomy remain high [6, 
7]. Therefore there is need for a more sensitive preopera-
tive diagnostic aid. This study was designed to investigate 
calprotectin as a potential biomarker for AA.
Appendix specimens from 52 patients following emer-
gency appendectomy for suspected AA were exam-
ined. The qualitative expression of calprotectin in these 
specimens was investigated via immunohistochemical 
analysis using calprotectin antibodies. While no or weak 
immunostaining was recorded within the appendix wall, 
excellent immunostaining was achieved in all cases both 
within the lumen of vermiform appendix irrespective of 
the extent of inflammation.
Calprotectin is a predominant protein found in the 
cytosol of neutrophil granulocytes and has been exten-
sively investigated with regards to intestinal disorders 
Fig. 1 a and b Immunostaining with Calprotectin antibody showing 
an uncomplicated appendicitis with unaltered luminal epithelial 
architecture. b detail to a. Note the immunohistochemical reaction of 
neutrophil granulocytes and the absence of immunostaining in the 
epithelium
Fig. 2 a and b Immunostaining with calprotectin antibody. Note the 
strong immunohistochemical reaction (red arrows a) in the granu-
locytes and the weak reaction over the apical epithelial membrane 
(black arrows, b)
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[4, 14, 16]. The measurement of calprotectin in stool for 
example is a standard diagnostic work-up in patients 
with Crohn´s disease, and the levels of fecal calprotectin 
in these patients have been shown to correlate with dis-
ease activity [17, 18]. Therefore, fecal calprotectin is a 
marker for intestinal inflammation.
The vermiform appendix as an intestinal organ is prin-
cipally not very different to the small and large bowels. 
Therefore an inflammation of the appendix as seen in 
AA could be associated with changes in the expression of 
calprotectin. This alluring theory was investigated in this 
pilot study.
The main findings in this study were the strong 
immunohistochemical reaction within the lumen of 
the inflamed appendix, the relatively weak immu-
nostaining over the epithelial membrane and the 
negative immunostaining in uninflamed vermi-
form appendix specimens. The finding of strong cal-
protectin expression in inflammatory cells within 
the lumen of the vermiform appendix supports 
the assumption that AA might be associated with 
changes in fecal calprotectin. It is therefore think-
able, that fecal calprotectin could be helpful in the 
diagnosis of AA.
Fecal calprotectin fulfills relevant criteria for a bio-
marker. It is easy to harvest without the need for an 
invasive procedure (bowel movement), is robust against 
enzymatic degradation and stabile at room temperature 
for more than 7 days [4, 19]. The probably most impor-
tant feature of fecal calprotectin as a possible diagnos-
tic aid for AA is the possibility of a rapid analysis with 
results within 15 min using commercially available point 
of care devices [16, 20, 21].
Taken together, the findings from this pilot study estab-
lish a direct association between AA and calprotectin. 
This study is the first step toward investigating a new 
biomarker for AA. We would be performing a quantita-
tive analysis of fecal calprotectin in patients with AA and 
would be able to present our results in the nearest future.
Conclusion
High calprotectin activity could be demonstrated within 
the lumen of vermiform appendix specimens following 
appendectomy for acute appendicitis. The high lumi-
nal accumulation of calprotectin-carrying cells could be 
interpreted as an invitation to study the expression of cal-
protectin in stool as a new diagnostic aid in patients with 
suspected appendicitis.
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